Discover

IDXX
IDEXX Laboratories, Inc.
511.65
1 x 511.14
1 x 501.77
bid
ask
+
5.17
1.02%
1 @ 07:30 PM
514.00 +2.35 (0.46%)
Ytd-24.37%
1y-21.95%
505.21
day range
516.43
504.70
52 week range
766.68
Open506.48Prev Close506.48Low505.21High516.43Mkt Cap40.31B
Vol1.12MAvg Vol602.88KEPS14.23P/E35.96Forward P/E30.57
Beta1.54Short Ratio3.41Inst. Own96.74%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0250-d Avg551.88200-d Avg598.531yr Est698.92

IDXX News

IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets
marketbeat.com
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets

IDEXX Laboratories NASDAQ: IDXX executives highlighted the company's diagnostic innovation pipeline,

IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference
marketbeat.com
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference

IDEXX Laboratories NASDAQ: IDXX executives reiterated the company's long-term growth framework at th

IDEXX Stock Gains Following the Acquisition of CoVet
zacks.com
IDEXX Stock Gains Following the Acquisition of CoVet

IDXX shares rise 0.6% after the company acquires CoVet, expanding its AI-native software capabilitie

IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection
gurufocus.com
IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detecti

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announc

IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection
businesswire.com
IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detecti

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX expands Faecal Dx™ antigen testing platform in the United K

IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence
businesswire.com
IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX announces acquisition of CoVetAI to advance veterinary work

IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
seekingalpha.com
IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference

IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference

Financial Analysis: IDEXX Laboratories (NASDAQ:IDXX) vs. InMode (NASDAQ:INMD)
defenseworld.net
Financial Analysis: IDEXX Laboratories (NASDAQ:IDXX) vs. InMode (NASDAQ:INMD)

InMode (NASDAQ: INMD - Get Free Report) and IDEXX Laboratories (NASDAQ: IDXX - Get Free Report) are

Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock
fool.com
Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock

The transaction involved 2,203 shares at $532.08 per share for a total value of ~$1.2 million. The d

Baird Financial Group Inc. Sells 6,500 Shares of IDEXX Laboratories, Inc. $IDXX
defenseworld.net
Baird Financial Group Inc. Sells 6,500 Shares of IDEXX Laboratories, Inc. $IDXX

Baird Financial Group Inc. decreased its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 7.9%

Arizona State Retirement System Purchases 1,074 Shares of IDEXX Laboratories, Inc. $IDXX
defenseworld.net
Arizona State Retirement System Purchases 1,074 Shares of IDEXX Laboratories, Inc. $IDXX

Arizona State Retirement System raised its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 4.

IDEXX Laboratories, Inc. $IDXX Stake Boosted by California State Teachers Retirement System
defenseworld.net
IDEXX Laboratories, Inc. $IDXX Stake Boosted by California State Teachers Retirement System

California State Teachers Retirement System raised its holdings in shares of IDEXX Laboratories, Inc

Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?
zacks.com
Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?

Baron Focused Growth Fund Q2 2026 Portfolio Update
seekingalpha.com
Baron Focused Growth Fund Q2 2026 Portfolio Update

Baron Focused Growth Fund rebounded in Q2 from a disappointing start to the year, with the Fund gain

IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
gurufocus.com
IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

[url="]IDEXX Laboratories, Inc.[/url] (Nasdaq: IDXX), a global leader in pet healthcare innovation,

IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
businesswire.com
IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet h

Idexx Laboratories (IDXX) is a Top-Ranked Growth Stock: Should You Buy?
zacks.com
Idexx Laboratories (IDXX) is a Top-Ranked Growth Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

American Capital Management Inc. Acquires Shares of 162,110 IDEXX Laboratories, Inc. $IDXX
defenseworld.net
American Capital Management Inc. Acquires Shares of 162,110 IDEXX Laboratories, Inc. $IDXX

American Capital Management Inc. bought a new position in shares of IDEXX Laboratories, Inc. (NASDAQ

Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock
zacks.com
Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?
zacks.com
Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?

IDXX's CAG diagnostics and cloud software growth support recurring revenues, while FX exposure and d

IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve
zacks.com
IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve

IDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international e

Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?
zacks.com
Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?

IDEXX pairs resilient diagnostics growth, margin gains and expanding innovation with a premium valua

benzinga.com
Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $710

Barclays analyst Glen Santangelo maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and

benzinga.com
UBS Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises t

benzinga.com
Citigroup Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

Citigroup analyst Daniel Grosslight maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and

Why Is IDEXX Laboratories Stock Gaining Tuesday?
benzinga.com
Why Is IDEXX Laboratories Stock Gaining Tuesday?

IDEXX Laboratories (IDXX) stock rose after reporting Q2 earnings of $4.27/share and $1.22B in revenu

IDEXX Laboratories Q2 2026 Earnings Call Transcript
benzinga.com
IDEXX Laboratories Q2 2026 Earnings Call Transcript

IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter financial results on Tuesday. The transcrip

benzinga.com
IDEXX Laboratories Raises FY2026 GAAP EPS Guidance from $14.45-$14.90 to $14.69-$14.94 vs $14.67 Est

IDEXX Laboratories (NASDAQ:IDXX) raises FY2026 GAAP EPS guidance from $14.45-$14.90 to $14.69-$14.94

benzinga.com
IDEXX Laboratories Q2 EPS $4.27 Beats $3.96 Estimate, Sales $1.217B Beat $1.201B Estimate

IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $4.27 per share which beat the analy

benzinga.com
UBS Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $620

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers t

benzinga.com
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years

Idexx Laboratories Raises Guidance On Higher Clinical Visits, Diagnostic Frequency
benzinga.com
Idexx Laboratories Raises Guidance On Higher Clinical Visits, Diagnostic Frequency

Idexx Laboratories shares edge higher as revenue tops estimates but earnings per share misses; guida

Transcript: IDEXX Laboratories Q1 2026 Earnings Conference Call
benzinga.com
Transcript: IDEXX Laboratories Q1 2026 Earnings Conference Call

benzinga.com
CORRECTION: IDEXX Laboratories Q1 EPS $3.47 Beats $3.41 Estimate, Sales $1.141B Beat $1.109B Estimat

IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $3.47 per share which beat the analy

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

benzinga.com
IDEXX Laboratories Raises FY2026 GAAP EPS Guidance from $14.29-$14.80 to $14.45-$14.90 vs $14.53 Est

IDEXX Laboratories (NASDAQ:IDXX) raises FY2026 GAAP EPS guidance from $14.29-$14.80 to $14.45-$14.90

benzinga.com
UBS Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $640

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers t

benzinga.com
Citigroup Initiates Coverage On IDEXX Laboratories with Neutral Rating, Announces Price Target of $6

Citigroup analyst Daniel Grosslight initiates coverage on IDEXX Laboratories (NASDAQ:IDXX) with a

benzinga.com
Stifel Maintains Buy on IDEXX Laboratories, Lowers Price Target to $675

Stifel analyst Jonathan Block maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and lowers th

benzinga.com
If You Invested $1000 In IDEXX Laboratories Stock 10 Years Ago, You Would Have This Much Today

benzinga.com
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 15 Years

benzinga.com
Piper Sandler Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $750

Piper Sandler analyst David Westenberg maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral

4 Analysts Have This To Say About IDEXX Laboratories
benzinga.com
4 Analysts Have This To Say About IDEXX Laboratories

benzinga.com
Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $800

Barclays analyst Glen Santangelo maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and

IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results
benzinga.com
IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results

benzinga.com
UBS Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $730

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers t

Roku To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Tuesday
benzinga.com
Roku To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Tuesday

benzinga.com
BTIG Maintains Buy on IDEXX Laboratories, Lowers Price Target to $800

BTIG analyst Mark Massaro maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and lowers the pr

Dow Jumps Over 500 Points Ahead Of Major Earnings: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
benzinga.com
Dow Jumps Over 500 Points Ahead Of Major Earnings: Investor Sentiment Improves, Fear Index Remains I

Dow Jones gains 500 points. Markets digest Trump's Fed chair nomination. CNN Money Fear & Gr

Russell 2000 Rallies, Gold And Silver Extend Losses: What's Moving Markets Monday?
benzinga.com
Russell 2000 Rallies, Gold And Silver Extend Losses: What's Moving Markets Monday?

Wall Street rebounded at the start of the new month after Friday's broad sell-off, but pressure